ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FAB Fusion Antibodies Plc

3.35
-0.10 (-2.90%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.90% 3.35 3.30 3.40 3.60 3.35 3.45 2,529,521 12:23:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0437 -0.77 1.99M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.45p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.875p.

Fusion Antibodies currently has 59,453,714 shares in issue. The market capitalisation of Fusion Antibodies is £1.99 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -0.77.

Fusion Antibodies Share Discussion Threads

Showing 3501 to 3521 of 4075 messages
Chat Pages: Latest  151  150  149  148  147  146  145  144  143  142  141  140  Older
DateSubjectAuthorDiscuss
22/5/2023
16:11
Another NI company HARL is doing very good , put me off to invest in here because company doesn't preserve shareholders value , placing 85% discounts price is awful
blackhorse23
22/5/2023
09:08
Interesting info on NI companies hedgehog. Owned some KNOS until recently
volsung
20/5/2023
20:36
What is fair value for FAB at the moment?

Let's try some robust valuation analysis.


Assuming full subscription for the 41,171,746 fundraising shares, added to existing 26,014,946 shares, then FAB will have 67,186,692 shares in issue. At 5p/share that would be a market cap. of c. £3.6M.; and c. £4.956M. at the current share price of 7.375p.

The company's H1 cash-burn was £800K., and the net fundraising cash if full subscription will be c. £1.42M.

It plans to cut costs, but revenue is collapsing: down massively to min. £2.8M. in 2023, but with about two thirds of that in H1.

So current annualised revenue based on H2 is probably below £2M., and the cash looks like it will probably be burnt within a year.

The CRO sector is very fragmented and competitive, and with reduced investment in the broader biotech sector, margins could come under pressure, to compound falling revenues.

From Wikipedia:-

" ... Organizations who have had success in working with a particular CRO in a particular context (e.g. therapeutic area) might be tempted or encouraged to expand their engagement with that CRO into other, unrelated areas; however, caution is required as CROs are always seeking to expand their experience and success in one area cannot reliably predict success in unrelated areas that might be new to the organization.[5] ...

As of 2013, there were over 1,100 CROs in the world, despite continued trends toward consolidation. Many CROs have been acquired while others have gone out of business.[9] ..."




By way of comparison with what you could get elsewhere for a market cap. of £5M., NWT (market cap. £5.015M.at 53.5p) announced a positive trading update this week:-

17/05/2023 07:00 UK Regulatory (RNS & others) Newmark Security PLC Year-end trading update LSE:NWT Newmark Security Plc

"Continued revenue growth and a return to profitability

Newmark Security plc (AIM: NWT), a leading provider of electronic, software and physical security systems, today provides an update on trading for the year ended 30 April 2023 ("FY23"), reaffirming the Company's return to profitability. ..."



NWT's FY revenue is expected to be £20M.+, & pre-tax profit £1M.+.

It's outlook is buoyant, and there's plenty of business for everyone.

hedgehog 100
20/5/2023
10:40
JakNife 6 Apr '23 - 18:29 - 3279 of 3333 0.010000 4 1
"Here's another hugely dilutive placing that's been agreed in the sector:

It's a chunky raise but at 1p it's an 84% discount to the closing price before it was previously suspended.
All arrows point to a fund raise for FAB that materially dilutes current shareholders.
JakNife"

Well done to JakNife ... his AGY example was even the precise % discount as FAB's.


dave454519 May '23 - 10:15 - 3283 of 3333 0 1 1
"Bloody hell that is savage.
At least they did not have the nerve to say they were "pleased" to announce"

Not in yesterday's first RNS Dave, but they still managed to get in two 'pleased to say/announce' yesterday:-

19/05/2023 10:00 UK Regulatory (RNS & others) Fusion Antibodies PLC Placing, Subscription and Retail Offer LSE:FAB Fusion Antibodies Plc
" ... Fusion Antibodies CEO, Adrian Kinkaid said : "We are pleased to say that we have been able to raise funds in an extremely challenging market, ..." ..."


19/05/2023 10:01 UK Regulatory (RNS & others) Fusion Antibodies PLC REX Retail Offer LSE:FAB Fusion Antibodies Plc
"Fusion Antibodies plc (AIM: FAB) is pleased to announce a retail offer via REX (the "REX Retail Offer") of ordinary shares ("Ordinary Shares") of 4 pence each in the capital of the Company (the "REX Retail Offer Shares")
... The issue price of the Placing Shares and Subscription Shares is 5 pence (the "Issue Price"). The price of the REX Retail Offer Shares is equal to the Issue Price. ..."



volsung 19 May '23 - 10:20 - 3288 of 3333 0 0 1
"Not the best Belfast share"

No, but the tiny number of London-listed N.I. shares includes former 15-bagger Kainos (KNOS) (still currently an 8.8-bagger from its 2015 IPO price of 139p); and FD Technologies (FDP) - currently a 37.6-bagger from its 2002 IPO price of 50p.

See the "Rockpool Acquisitions (ROC)" thread for details (it's a Northern Ireland shell company currently arranging a RTO):-

hedgehog 100
19/5/2023
22:14
Mr MacGregor - 27 Feb 2022 - 17:20:23 - 2149 of 3332 ☆ Fusion Antibodies: from discovery to Clinical supply ☆ - FAB
Whatsthepoint is certainly well named, and an idiot as evidenced by holding shares in this donkey. Simon Douglas poundshop chairman of FAB and ODX, CEOs a blur. Massive red flags. You have been warned.

mr macgregor
19/5/2023
19:38
Okay, hopefully we can have a chat at an AGM soon.

SSB

sideshowbull
19/5/2023
19:28
>>>SSB

Yes, I was inside on this one (Project Hazel) and bought a few in the placing (EIS qualifying). I might buy a few more in the REX offer too should the price remains at a decent premium to the placing price

timbo003
19/5/2023
18:20
Tim were you inside on this?

Allenby again!

Which muppets would ever use them as brokers?

Oh Fk..


No advice

BWTFDIK

sideshowbull
19/5/2023
15:39
New Allenby research note available here (Rose tinted reading glasses recommended):
timbo003
19/5/2023
14:48
this massive discounted placing is completely wipe out existing shareholders , bad management
blackhorse23
19/5/2023
12:56
TWD was the worst 1p when 13p !
dave4545
19/5/2023
12:21
Those that bought at 5p will be delighted to see PI's still giving them such a generous profit so quickly.

Jam tomorrow from the company will be the order of the day now.

Maybe WTP will show his face now and I doubt he will feature in the next update of major shareholders as he will have been diluted to such an extent and may not have had the cash or the inclination to take up new shares having been stripped of a lot of wealth. It happens to us all at times, one way or another - you just have to pick yourself up and learn from it.

clocktower
19/5/2023
11:58
I've never seen such a discount, in all my years, thats sickening.
festario
19/5/2023
11:44
I did warn you but a nice profit for several this morning.

Thanks be to them.😀ԅ12;

clocktower
19/5/2023
11:35
Placing 5p ?? No wonder
blackhorse23
19/5/2023
11:34
I see that the CFO has scarpered, not surprised really as he has been telling investors for the last couple of years that the company shouldn't require further funds to reach cash break even 😦
timbo003
19/5/2023
11:25
Good luck chaps -
tomboyb
19/5/2023
11:23
Lifestyle company for the directors imo.
clocktower
19/5/2023
11:19
I for one am utterly shocked! Shocked I tell ya!
kemche
19/5/2023
11:13
Director bought at 41p Nov 2022
mally6
19/5/2023
11:12
TFL Sold back in Feb last year
pugugly
Chat Pages: Latest  151  150  149  148  147  146  145  144  143  142  141  140  Older